scholarly journals Developing CAM Research Capacity for Complementary Medicine

2006 ◽  
Vol 3 (2) ◽  
pp. 283-289 ◽  
Author(s):  
George Lewith ◽  
Marja Verhoef ◽  
Mary Koithan ◽  
Suzanna M. Zick
Keyword(s):  
United States ◽  
Health Care ◽  
United Kingdom ◽  
Alternative Medicine ◽  
Research Policy ◽  
Research Capacity ◽  
The United States ◽  
Research Strategy ◽  
Future Research ◽  
The United Kingdom

This article describes initiatives that have been central to the development of complementary and alternative medicine (CAM) research capacity in the United Kingdom, Canada and the United States over the last decade. While education and service delivery are essential parts of the development of CAM, this article will focus solely on the development of research strategy. The development of CAM research has been championed by both patients and politicians, primarily so that we may better understand the popularity and apparent effectiveness of these therapies and support integration of safe and effective CAM in health care. We hope that the perspective provided by this article will inform future research policy.

scholarly journals Bisexual Lives and Aging in Context: A Cross-National Comparison of the United Kingdom and the United States

2019 ◽  
Vol 89 (1) ◽  
pp. 22-38 ◽  
Author(s):  
Sarah Jen ◽  
Rebecca L. Jones
Keyword(s):  
United States ◽  
United Kingdom ◽  
Life Course ◽  
Later Life ◽  
The United States ◽  
Life Course Perspective ◽  
Future Research ◽  
Racial Relations ◽  
Aids Epidemic ◽  
The United Kingdom

Research on bisexual histories and identities in later life is limited and reflects only single-nation studies. This article compares findings from two independently conducted studies of bisexual aging, in the United Kingdom and the United States, using a discourse analytic and life course perspective. The goals were to compare how participants narrated and made sense of their bisexual experiences in later life and to examine ways in which historical and cultural contexts shaped their accounts. Findings indicate that similar histories around lesbian separatism and the HIV/AIDS epidemic enabled shared discursive resources, while differing ethnic and racial relations enabled distinctive discursive possibilities. In both studies intersectional experiences, particularly including being a person of color and having a transgender history, profoundly affected individual narratives. Future research will benefit from creative conceptualizations of bisexuality, applying the life course perspective in research and practice, and supporting the diverse and resilient ways bisexual older adults use language.

scholarly journals Cancer Drugs: An International Comparison of Postlicensing Price Inflation

2017 ◽  
Vol 13 (6) ◽  
pp. e538-e542 ◽  
Author(s):  
Philip Savage ◽  
Sarah Mahmoud ◽  
Yogin Patel ◽  
Hagop Kantarjian
Keyword(s):  
United States ◽  
Health Care ◽  
United Kingdom ◽  
The United States ◽  
Cancer Drug ◽  
Cancer Drugs ◽  
Price Inflation ◽  
Drug Prices ◽  
The United Kingdom ◽  
Price Increases

Purpose: The cost of cancer drugs forms a rising proportion of health care budgets worldwide. A number of studies have examined international comparisons of initial cost, but there is little work on postlicensing price increases. To examine this, we compared cancer drug prices at initial sale and subsequent price inflation in the United States and United Kingdom and also reviewed relevant price control mechanisms. Methods: The 10 top-selling cancer drugs were selected, and their prices at initial launch and in 2015 were compared. Standard nondiscounted prices were obtained from the relevant annual copies of the RED BOOK and the British National Formulary. Results: At initial marketing, prices were on average 42% higher in the United States than in the United Kingdom. After licensing in the United States, all 10 drugs had price rises averaging an overall annual 8.8% (range, 1.4% to 24.1%) increase. In comparison, in the United Kingdom, six drugs had unchanged prices, two had decreased prices, and two had modest price increases. The overall annual increase in the United Kingdom was 0.24%. Conclusion: Cancer drug prices are rising substantially, both at their initial marketing price and, in the United States, at postlicensing prices. In the United Kingdom, the Pharmaceutical Price Regulation Scheme, an agreement between the government and the pharmaceutical industry, controls health care costs while allowing a return on investment and funds for research. The increasing costs of cancer drugs are approaching the limits of sustainability, and a similar government-industry agreement may allow stability for both health care provision and the pharmaceutical industry in the United States.

Utilization of Health Care Coalitions and Resiliency Forums in the United States and United Kingdom: Different Approaches to Strengthen Emergency Preparedness

2015 ◽  
Vol 10 (1) ◽  
pp. 161-164 ◽  
Author(s):  
John Walsh ◽  
Allan Graeme Swan
Keyword(s):  
United States ◽  
Health Care ◽  
United Kingdom ◽  
Emergency Management ◽  
Emergency Preparedness ◽  
Health Care Systems ◽  
Management Strategies ◽  
The United States ◽  
The United Kingdom ◽  
Care Systems

ABSTRACTThe process for developing national emergency management strategies for both the United States and the United Kingdom has led to the formulation of differing approaches to meet similar desired outcomes. Historically, the pathways for each are the result of the enactment of legislation in response to a significant event or a series of events. The resulting laws attempt to revise practices and policies leading to more effective and efficient management in preparing, responding, and mitigating all types of natural, manmade, and technological hazards. Following the turn of the 21st century, each country has experienced significant advancements in emergency management including the formation and utilization of 2 distinct models: health care coalitions in the United States and resiliency forums in the United Kingdom. Both models have evolved from circumstances and governance unique to each country. Further in-depth study of both approaches will identify strengths, weaknesses, and existing gaps to meet continued and future challenges of our respective disaster health care systems. (Disaster Med Public Health Preparedness. 2016;10:161–164)

Sign in / Sign up

Export Citation Format

Share Document